Concern over EU biotechnology strategy
The European Association for Bioindustries (EuropaBio) has released a 'healthcare manifesto', calling for prompt implementation of the European Union's (EU) 2002 strategy to promote biotechnology.
The European Association for Bioindustries (EuropaBio) has released a 'healthcare manifesto', calling for prompt implementation of the European Union's (EU) 2002 strategy to promote biotechnology.
The federation said the EU was the only region worldwide to have such a plan, and it was disappointed that it had not been rolled out.
The manifesto stressed 'biotechnology will be essential as practically all future medicines will use healthcare biotechnology in the R&D process and/or in manufacturing'. It detailed seven policies required to restore European worldwide leadership in biotechnology, promoting orphan drugs, bioethics standards, targeted therapies, and sophisticated economic assessments of biotechnological medicines.